PHOSP-COVID Post-hospitalisation COVID-19 study: a national consortium to understand and improve long-term health outcomes

PHOSP-COVID 住院后 COVID-19 研究:了解和改善长期健康结果的国家联盟

基本信息

  • 批准号:
    MR/V027859/1
  • 负责人:
  • 金额:
    $ 1135.86万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2020
  • 资助国家:
    英国
  • 起止时间:
    2020 至 无数据
  • 项目状态:
    未结题

项目摘要

The COVID-19 pandemic has tragically led to severe acute illness, hospitalisation and death. Beyond the health of those affected, it has had widespread economic, psychological and societal effects. The clinical spectrum is broad, ranging from those with no or minimal symptoms to severe pneumonia in 15-20% with evidence of widespread disease beyond the lung. As we emerge from the first wave of the pandemic we have new insights into the acute phase of this disease but very little information concerning longterm effects of COVID-19 and the ongoing medical, psychological and rehabilitation needs of these patients. We shall establish a national consortium and a research platform embedded within clinical care to understand and improve long-term outcomes for survivors following hospitalisation with COVID-19. We have built the consortium from existing expert groups across the UK and shall use standardised assessments of patients, including advanced imaging, recording of information and collection of samples. This study will provide us with a comprehensive understanding of the impact on the health of those that have been hospitalised with COVID-19. This will enable trials of new strategies of clinical care including personalised treatments to improve the long-term outcome of current and future COVID-19 survivors.
199年的大流行导致严重的急性疾病,住院和死亡。除了受影响的人的健康之外,它还具有广泛的经济,心理和社会影响。临床光谱广泛,从没有或最少症状的临床范围到15-20%的严重肺炎,肺部广泛疾病的证据以外。当我们从大流行的第一波中出现时,我们对这种疾病的急性阶段有了新的见解,但是关于Covid-19的长期影响以及这些患者持续的医疗,心理和康复需求的信息很少。我们将建立一个国家财团和一个嵌入临床护理中的研究平台,以理解和改善Covid-19的住院后幸存者的长期成果。我们已经从英国现有专家团体建立了财团,并应对患者的标准评估,包括高级成像,记录信息和样本收集。这项研究将使我们对与Covid-19的患者的健康影响有关对健康的影响的影响。这将实现对新的临床护理策略的试验,包括个性化治疗方法,以改善当前和未来的Covid-19幸存者的长期结果。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Longitudinal trajectory of cardiac magnetic resonance and cardiopulmonary exercise testing findings in moderate to severe COVID-19 and association with symptoms
中度至重度 COVID-19 心脏磁共振和心肺运动测试结果的纵向轨迹及其与症状的关联
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    39.3
  • 作者:
    Cassar M. P.
  • 通讯作者:
    Cassar M. P.
Cohort profile: post-hospitalisation COVID-19 study (PHOSP-COVID)
  • DOI:
    10.1101/2023.05.08.23289442
  • 发表时间:
    2023-01-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Elneima, O.
  • 通讯作者:
    Elneima, O.
Impact of ethnicity on the accuracy of measurements of oxygen saturations: A retrospective observational cohort study.
  • DOI:
    10.1016/j.eclinm.2022.101428
  • 发表时间:
    2022-06
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
  • 通讯作者:
Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR, CPET and lung function testing post-COVID-19.
  • DOI:
    10.1016/j.eclinm.2021.101159
  • 发表时间:
    2021-11
  • 期刊:
  • 影响因子:
    15.1
  • 作者:
    Cassar MP;Tunnicliffe EM;Petousi N;Lewandowski AJ;Xie C;Mahmod M;Samat AHA;Evans RA;Brightling CE;Ho LP;Piechnik SK;Talbot NP;Holdsworth D;Ferreira VM;Neubauer S;Raman B
  • 通讯作者:
    Raman B
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium.
  • DOI:
    10.1186/s13063-023-07093-7
  • 发表时间:
    2023-01-26
  • 期刊:
  • 影响因子:
    2.5
  • 作者:
    Daynes, Enya;Baldwin, Molly;Greening, Neil J.;Yates, Thomas;Bishop, Nicolette C.;Mills, George;Roberts, Matthew;Hamrouni, Malik;Plekhanova, Tatiana;Vogiatzis, Ioannis;Echevarria, Carlos;Nathu, Rashmita;McAuley, Hamish J. C.;Latimer, Lorna;Glennie, Jennifer;Chambers, Francesca;Penfold, Ruth;Hume, Emily;Magaritis, Dimitrios;Alexiou, Charikleia;Potthoff, Sebastian;Hogg, Mitchell James;Haighton, Catherine;Nichol, Bethany;Leavy, Olivia C.;Richardson, Matthew;Elneima, Omer;Singapuri, Amisha;Sereno, Marco;Saunders, Ruth M.;Harris, Victoria C.;Nolan, Claire M.;Bolton, Charlotte;Houchen-Wolloff, Linzy;Harrison, Ewen M.;Lone, Nazir;Quint, Jennifer;Chalmers, James D.;Ho, Ling-Pei;Horsley, Alex;Marks, Michael;Poinasamy, Krisnah;Ramen, Betty;Wain, Louise V.;Brightling, Christopher;Man, William D. -C.;Evans, Rachael;Singh, Sally J.
  • 通讯作者:
    Singh, Sally J.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher Brightling其他文献

Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
  • DOI:
    10.1016/j.jaci.2023.11.879
  • 发表时间:
    2024-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Mario Castro;Alberto Papi;Celeste Porsbjerg;Njira Lugogo;Christopher Brightling;Francisco-Javier González-Barcala;Arnaud Bourdin;Mykola Ostrovskyy;Maria Staevska;Pai-Chen Chou;Liliana Duca;Ana Pereria;Charles Fogarty;Rufai Nadama;Mei Zhang;Amelie Rodrigues;Xavier Soler;Simona Pantelimon;Harry Sacks;Yamo Deniz
  • 通讯作者:
    Yamo Deniz
Section 3. A Discussion of Flexible Dosing and Patient-Centered Therapy: Highlights of the Asthma Summit 2009: Beyond the Guidelines
  • DOI:
    10.1097/wox.0b013e3181d27cd8
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    G. Walter Canonica;Christopher Brightling
  • 通讯作者:
    Christopher Brightling
Procalcitonin and C reactive protein in patients hospitalised with acute respiratory illness
  • DOI:
    10.1016/j.jinf.2010.09.012
  • 发表时间:
    2010-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Tristan Clark;Mona Bafadel;Carlene Reid;Marie-jo Medina;Michael Barer;Christopher Brightling;Karl Nicholson
  • 通讯作者:
    Karl Nicholson

Christopher Brightling的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher Brightling', 18)}}的其他基金

East Midlands Breathomics Pathology Node (EMBER)
东米德兰兹呼吸组学病理学节点 (EMBER)
  • 批准号:
    MR/N005880/1
  • 财政年份:
    2015
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Research Grant
MRC/ABPI COPD Consortium Work Package 1: COPD Phenotyping
MRC/ABPI COPD 联盟工作包 1:COPD 表型分析
  • 批准号:
    G1001365/1
  • 财政年份:
    2011
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Research Grant
Biomarkers to target antibiotic and systemic corticosteroid therapy in COPD exacerbations
COPD 恶化时针对抗生素和全身皮质类固醇治疗的生物标志物
  • 批准号:
    G0601369/1
  • 财政年份:
    2007
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Research Grant

相似国自然基金

树脂糖苷类Sec61α抑制剂的发现及其潜在抗冠状病毒活性研究
  • 批准号:
    32370419
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
靶向冠状病毒主蛋白酶抑制剂药物分子的自适应结构描述与精准设计合成
  • 批准号:
    22373062
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
  • 批准号:
    82370569
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
中医药治疗新型冠状病毒感染恢复期多系统多维度评价指标集及测量方法研究
  • 批准号:
    82305437
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
呼吸系统冠状病毒交叉反应性T细胞识别图谱及作用机制研究
  • 批准号:
    82301996
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Post-COVID-19 Multicultural Community Building in Japan: Enhancing Risk Communication and Resilience among Foreign Residents
COVID-19 后日本的多元文化社区建设:加强外国居民的风险沟通和抵御能力
  • 批准号:
    24K15447
  • 财政年份:
    2024
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Socio-economic Impact of the Post-COVID-19 Condition in the Canadian Context
COVID-19 后疫情对加拿大的社会经济影响
  • 批准号:
    494280
  • 财政年份:
    2023
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Operating Grants
Long COVID in Bangladesh: Developing Strategies for Identifying and Managing Post-COVID Syndrome in LMIC and Low Resource Health Systems
孟加拉国的长期新冠疫情:制定识别和管理中低收入国家和资源匮乏卫生系统中新冠肺炎后综合症的策略
  • 批准号:
    494270
  • 财政年份:
    2023
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Operating Grants
The Role of Film Tourism in the Destination Marketing in the Post-Covid Era: A Case Study of Hokkaido, Japan
后疫情时代电影旅游在目的地营销中的作用:以日本北海道为例
  • 批准号:
    23K17128
  • 财政年份:
    2023
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Did business support measures during COVID-19 pandemic create Zombie firms?: Evidence from Post-pandemic corporate performance
COVID-19 大流行期间的企业支持措施是否创造了僵尸公司?:大流行后企业绩效的证据
  • 批准号:
    23K18808
  • 财政年份:
    2023
  • 资助金额:
    $ 1135.86万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了